Humana Stock News

LOUISVILLE, Ky.--(BUSINESS WIRE)--A new research study finds an association between pharmacy care coordination services and improved health outcomes for cancer patients.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced the results of Humana Community Day 2026, the company's annual nationwide day of service. In its third year, Humana Community Day mobilized more than 18,000 employees across 28 states and Puerto Rico, supported 1,200 nonprofit organizations, and positively impacted 2.25 million lives and community members through voluntee...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® Recognition.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on November 27, 2026 to stockholders of record as of the close of business on October 30, 2026. About Humana Humana (NYSE: HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell...

LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM), today announced 80 winners of college scholarships awarded through the Humana Foundation Scholarship Program. Scholarships provide up to $3,000 for postsecondary education, including degree, vocational and technical programs, for children of Humana employees. Annual awards are renewable fo...

Following a parade of health insurance company earnings reports this summer, stocks are rising and costs appear to be under control for now.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today announced that Shantanu Nundy, M.D., will join the company as Chief Medical Officer, effective August 31. A practicing physician, healthcare executive, and technology leader, Dr. Nundy has spent his career using technology to make care better, simpler, and more human. At Humana, he will bring an innovative clinical voice to the ent...

Health insurer Humana has ‌agreed not to refer to drugmaker Teva as an Israeli company at an upcoming U.S. drug price-fixing trial, after the drugmaker said public views on the Gaza war could unfairly influence jurors.